ASA in the News
By Laura Hancock Casper Star Tribune
Gretchen Wheeler knows her 21-year-old daughter will never be able to drive, marry or have her own children. Katelyn will likely live with her mother "forever," Wheeler says.
She is willing to accept some of those facts. Her daughter has epilepsy and autism.
What Wheeler can't accept is Katelyn's constant seizures.
Medical Marijuana: You don't have to smoke it and it doesn't make you high - Americans for Safe Access
By Leslie Khan Chicago Now
I find myself saying this to people on a regular basis when talking about medical marijuana. This still seems to be the biggest misconception about medical marijuana. These days, the most effective and easiest way to get the most benefit from the plant is via oil which you take by mouth. The THC level (ingredient that gets you high) in the oil is very, very low and is often referred to as "hemp or realm oil." In addition, you can vape it, dab it, use it in a vaporizer, drink it in a tea, apply it through a tincture, eat it in a brownie and of course, smoke it, using all sorts of different paraphernalia.
By Jaime Williams MMJ Observer
When President Barack Obama was getting into office back in 2008, he owed up to a promise that his administration would give the war on drugs a different approach. The promise has since been fulfilled with the lifting of the enduring restriction on medical marijuana research. The move has been hailed by a majority of marijuana reform advocates citing that this is victorias enough.
On Monday, the California Senate voted 33-1 to pass a bill (AB 258) that would prevent individuals from being denied an organ transplant because they use medical marijuana, the AP/Sacramento Bee reports (AP/Sacramento Bee, 6/22).
The White House today lifted a longstanding restriction on medical marijuana research, giving a green light to a growing group of mainstream scientists who are interested in investigating the potential health benefits of pot. Such research will no longer have to undergo review by the Public Health Service, a process ostensibly meant to ensure the use of scientifically valid clinical trials, but in practice has served as a barrier to launching studies. A bipartisan group of lawmakers, and even opponents of legalization, had called for the requirement to be lifted.
By Josh Long Natural Products Insider
In reliance on a drug trial that was announced eight years ago, FDA has determined CBD cannot be marketed as a dietary supplement.
FDA could change its mind, but only if it is provided evidence that CBD was marketed as a supplement or conventional food before GW Pharmaceuticals plc announced that a clinical trial had been initiated in the United States to study Sativex, a drug that was used to treat pain in patients who suffered from advanced cancer. The drug is composed mostly of two cannabinoids: CBD and THC, the psychoactive ingredient in marijuana.
By Gloria Tatum Atlanta Progressive News
(APN) ATLANTA — The Georgia Commission on Medical Cannabis–created by the General Assembly as part of a compromise with Gov. Nathan Deal, to explore in-state medical cannabis cultivation–met at the State Capitol on Tuesday, June 16, 2015 to discuss guidelines to access medical cannabis in Georgia.
By Bob Egelko San Francisco Chronicle
Dianne Feinstein, long one of the Senate’s foremost drug warriors, has shown signs recently of mellowing on the issue of medical marijuana. She’s voted to allow its use by military veterans, pressed for more federal research into the drug and expressed sympathy for marijuana patients.
By Mark Walker Argus Leader
Six-hundred fifty miles.
That's the length Melissa Mentele has gone in search of relief.
Mentele has lived with chronic pain since a 2012 workplace injury. She was moving a nursing home resident who suddenly resisted, permanently damaging Mentele's arm and shoulder in the process.
By Tim Strombel Cashinbis
Last Wednesday the House of Representatives renewed an amendment that blocks federal prosecution of Cannabis operations; provided they are in compliance with state law. This week the Senate has also jumped on the bandwagon, passing the similarly worded Mikulski Medical Cannabis Amendment by a vote of 20-10. This vote marks the first time the Senate has weighed in on medical Cannabis programs at the state level. These amendments, passed within a week of each other, combine to send a very reassuring message to the medical community. Government officials are seeing the positive impact being made by the industry, both financially and medically.